Liposome mediated antigen delivery leads to induction of CD8+ T lymphocyte and antibody responses against the V3 loop region of HIV gp120

Cellular Immunology

Volumn 210, Issue 1, 2001, Pages 49-55

  Ahmad, Nadeem ^a   Khan, Masood A ^b   Owais, M ^b  

^a HAMDARD UNIVERSITY   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Cellular immunity; Cytotoxic T lymphocytes; E. coli lipids; Fusogenic liposomes; Vaccines

Indexed keywords

ESCHERIOSOME; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIPOSOME; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; ESCHERICHIA COLI; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT; VACCINATION; VIRUS ENVELOPE;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035946843     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.2001.1805     Document Type: Article

References (27)

1. + T cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosis
2. +, MHC-restricted cytotoxic T cells that lyse parasite infected target cells
3. + T cells
4. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins
5. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long term asymptomatics
6. Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: Evidence for preferential expansion of Th-2 cells
7. + T lymphocytes specific for an epitope of the 16-kD α crystalline antigen of Mycobacterium tuberculosis
8. Immunogenicity and adverse effects of inactivated virosomes versus alum adsorbed Hepatitis A vaccine: A randomized controlled trial
9. + cytotoxic T lymphocytes
10. Liposome mediated cytosolic delivery of macromolecules and its possible use in vaccine development
11. Influence of changes in polar head group composition on the lipid phase transition and characterization of a mutant containing only saturated phospholipid acyl chains
12. Development of artificial vaccines against HIV using defined epitopes
13. A method for adsorbent fractionation of cottonseed oil for experimental intravenous fat emulsions
14. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
15. High encapsulation efficiencies in sized liposomes produced by extrusion of dehydration-rehydration vesicles
16. An immunodominant class-I restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II restricted help for itself
17. Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice
18. Protein mediated membrane fusion
19. Phosphatidylethanolamine liposomes: Drug delivery, gene transfer and immunodiagnostic applications
20. Immunogenicity of synthetic HIV-1 loop peptides by MPL adjuvanted pH sensitive liposomes
21. Envelope protein and p18 (III B) peptide recognized by cytotoxic t lymphocytes from humans immunized with HIV envelope
22. Modification of delivery system enhances MHC nonrestricted immunogenicity of V3 loop region of HIV-1 gp 120
23. Liposomes as carriers of peptide antigens: Induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides
24. T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing Hepatitis B vaccine: Demonstration of superior anti-SHBs antibody induction in responder mice
25. + T cell responses in mice homozygous for disruption of the interleukin-4 gene
26. A strategy for prophylactic vaccination against HIV